Skip main navigation

Regulating the future

Interview with Juliet Tizzard of the HFEA about the regulatory situation in the UK when it comes to genome editing.

In this interview, Juliet Tizzard of the HFEA explains the difference between embryo research and embryo treatment. This separation is what allows research on genome editing to develop in the UK.

The UK is almost unique in this way, as many countries around the world have not made this distinction, and so they have not allowed genome editing for research.

This distinction allows new techniques to be developed in the laboratory, so that it can be tested and safeguarded, and is one of the ways in which the HFEA is able to support novel research in the area of gene editing and other fields.

For discussion: If you come from a country other than the UK, please share how you think this technology would be received in your country. In doing so, please explain why you think it would be received in that way.

This article is from the free online

Making Babies in the 21st Century

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now